CA Healthcare Acquisition Corp. (CACH), a SPAC looking to invest in growth-oriented companies in the health care industry, found what it was looking for in London-headquartered LumiraDx Limited. The two entities have reached a definitive merger agreement that will list LumiraDx on Nasdaq under "LMDX" and gives the company a valuation of $5 billion.